TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa

Individual and community social and health-related factors, along with acceptability of TPT, might affect uptake and retention. While TPT was seen as important, concerns about side effects and dual treatment burdens highlight the need for improved education and support. Strengthening healthcare communication, expanding TPT information, and promoting TPT as a proactive health decision may motivate uptake.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-10-16
DOI
https://doi.org/10.1371/journal.pone.0333367
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa

Kate Shearer, Minja Milovanovic, Nombuyiselo J. Mofokeng, Limakatso Lebina et al.
PLoS ONE
Tuberculosis Research and Epidemiology
article

TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa

Kate Shearer, Minja Milovanovic, Nombuyiselo J. Mofokeng, Limakatso Lebina, Laura Steiner, Jill Owczarzak, Christopher J. Hoffmann, Leisha Genade, Neil Alexander Martinson, Lebohang Mlambo, Matshepo Setlaleleng, Phineas Ndou
article en

Abstract

Individual and community social and health-related factors, along with acceptability of TPT, might affect uptake and retention. While TPT was seen as important, concerns about side effects and dual treatment burdens highlight the need for improved education and support. Strengthening healthcare communication, expanding TPT information, and promoting TPT as a proactive health decision may motivate uptake.

PLoS ONEVol. 20(10)
Johns Hopkins University (US), Johns Hopkins Medicine (US), Africa Health Research Institute (ZA), African Explosives (South Africa) (ZA), Perinatal HIV Research Unit (ZA)
Openalex Percentile: Top 65%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa — Kate Shearer, Minja Milovanovic, et al. · PLoS ONE (2025) | TGRS Research Map | TGRS